2,609
Views
42
CrossRef citations to date
0
Altmetric
REVIEWS

HELLP syndrome: Understanding and management of a pregnancy-specific disease

, , , , , & show all
Pages 331-337 | Published online: 08 May 2013

References

  • Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. 1999. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? American Journal of Obstetrics and Gynecology 180:221–225.
  • Aliefendioğlu D, Yurdakök M, Oran O, Erdem G, Tekinalp G, Onderoğlu L. 2000. Neonatal morbidity and mortality associated with maternal HELLP syndrome. Turkish Journal of Pediatrics 42:308–311.
  • Aslan H, Gul A, Cebeci A. 2004. Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome. Gynecologic and Obstetric Investigation 58:96–99.
  • Barton JR, Sibai BM. 2009. Gastrointestinal complications of pre-eclampsia. Seminars in Perinatology 33:179–188.
  • Baxter JK, Weinstein L. 2004. HELLP syndrome: the state of the art. Obstetrical and Gynecological Survey 59:838–845.
  • Bayraktaroğlu Z, Demirci F, Balat O, Kutlar I, Okan V, Uğur G. 2006. Plasma exchange therapy in HELLP syndrome: a single-center experience. Turkish Journal of Gastroenterology 17:99–102.
  • Bick RL. 2000. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management. Hematology/Oncology Clinics of North America 14:999–1044.
  • Bonney EA. 2007. Preeclampsia: a view through the danger model. Journal of Reproductive Immunology 76:68–74.
  • Ch’Ng CL, Morgan M, Hainsworth I, Kingham JGC. 2002. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 51:876–880.
  • Dart BW 4th,Cockerham WT, Torres C, Kipikasa JH, Maxwell RA. 2004. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. Journal of Trauma 57:171–174.
  • Doshi S, Zucker SD. 2003. Liver emergencies during pregnancy. Gastroenterology Clinics of North America 32:1213–1227.
  • Ertan AK, Wagner S, Hendrik HJ, Tanriverdi HA, Schmidt W. 2002. Clinical and biophysical aspects of HELLP-syndrome. Journal of Perinatal Medicine 30:483–489.
  • Eser B, Guven M, Unal A, Coskun R, Altuntas F, Sungur M, et al. 2005. The role of plasma exchange in HELLP syndrome. Clinical and Applied Thrombosis/Hemostasis 11:211–217.
  • Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship TH, et al. 2008a. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111:624–632.
  • Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. 2008b. Advances in understanding of pathogenesis of aHUS and HELLP. British Journal of Haematology 143:336–348.
  • Franchini M. 2006. Haemostasis and pregnancy. Thrombosis and Haemostasis 95:401–413.
  • Garg R, Nath MP, Bhalla AP, Kumar A. 2009. Disseminated intravascular coagulation complicating HELLP syndrome: perioperative management. BMJ Case Report 2009, pii: bcr10. 2008. s1027.
  • Gilboa Y, Bardin R, Feldberg D, Bachar GN. 2006. Postpartum hepatic rupture and retroperitoneal hematoma associated with HELLP syndrome. Israel Medical Association Journal 8:219–220.
  • Gortner L, Pohlandt F, Bartmann P, Terinde R, Versmold H, Dorigo O. 1992. Short-term outcome in infants with birth weights less than 1750 g born to mothers with HELLP syndrome. Journal of Perinatal Medicine 20: 25–28.
  • Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. 2005. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecologic and Obstetric Investigation 59:113–118.
  • Habli M, Eftekhari N, Wiebracht E, Bombrys A, Khabbaz M, How H, et al. 2009. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. American Journal of Obstetrics and Gynecology 201:385.e1–e5.
  • Haddad B, Sibai BM. 2005. Expectant management of severe preeclampsia: proper candidates and pregnancy outcome. Clinical Obstetrics and Gynecology 48:430–440.
  • Haram K, Svendsen E, Abildgaard U. 2009. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 9:8.
  • Harms K, Rath W, Herting E, Kuhn W. 1995. Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. American Journal of Perinatology 12:1–6.
  • Holub M, Bodamer OA, Item C, Mühl A, Pollak A, Stöckler-Ipsiroglu S. 2005. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatrica 94:48–52.
  • Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, et al. 2003. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymesand low platelets (HELLP) syndrome. Journal of Thrombosis and Haemostasis 4:2569–2575.
  • Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. 1999. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. American Journal of Obstetrics and Gynecology 181:924–928.
  • Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN Jr. 2001. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. American Journal of Obstetrics and Gynecology 184:1332–1337.
  • Isler CM, Rinehart BK, Terrone DA, May WL, Magann EF, Martn JN Jr. 2003. The importance of parity to major maternal morbidity in the eclamptic mother with HELLP syndrome. Hypertension in Pregnancy 22:287–294.
  • Juárez-Azpilcueta A, Motta-Martínez E, Montaño-Uzcanga A. 2003. Hepatic rupture as a complication of hypertensive disease of pregnancy maternal and the HELLP syndrome. Gaceta Medica de Mexico 139:276–280.
  • Kandler C, Kevekordes B, Zenker M, Kandler M, Beinder E, Lang N, et al. 1998. Prognosis of children born to mothers with HELLP syndrome. Journal of Perinatal Medicine 26:486–490.
  • Knapen MF, Peters WH, Mulder TP, Merkus HM, Jansen JB, Steegers EA. 1999. Plasma glutathione S-transferase Pi 1–1 measurements in the study of hemolysis in hypertensive disorders of pregnancy. Hypertension in Pregnancy 18:147–156.
  • Koenen SV, Huisjes AJ, Dings J, van der GY, Visser GH, Bruinse HW. 2006. Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? Journal of Maternal-Fetal and Neonatal Medicine 19:93–99.
  • Magann EF, Martin JN Jr. 1999. Twelve steps to optimal management of HELLP syndrome. Clinical Obstetrics and Gynecology 42:532–550.
  • Maher MM, Kalra MK, Lucey BC, Jhaveri K, Sahani DV, Hahn PF, et al. 2004. Haemolysis, elevated liver enzymes and low platelets syndrome: ultrasound and magnetic resonance imaging findings in the liver. Australasian Radiology 48:64–68.
  • Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. 1999. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. American Journal of Obstetrics and Gynecology 180:1373–1384.
  • Martin JN Jr, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. 2003. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. American Journal of Obstetrics and Gynecology 189:830–834.
  • Martin JN Jr, Rose CH, Briery CM. 2006. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. American Journal of Obstetrics and Gynecology 195:914–934.
  • Matchaba C, Moodley J. 2009. WITHDRAWN: Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Systematic Reviews(3):CD002076.
  • Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP. 2004. Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstetrics and Gynecology 103:1055–1058.
  • Miguelote RF, Costa V, Vivas J, Gonzaga L, Menezes CA. 2009. Postpartum spontaneous rupture of a liver hematoma associated with preeclampsia and HELLP syndrome. Archives of Gynecology and Obstetrics 279: 923–926.
  • Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. 2007. HELLP syndrome – a multisystemic disorder. Journal of Gastrointestinal and Liver Diseases 16:419–424.
  • Moake J. 2009. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Practice and Research. Clinical Haematology 22:567–576.
  • Molvarec A, Rigó J Jr, Bõze T, Derzsy Z, Cervenak L, Makó V, et al. 2009. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thrombosis and Haemostasis 101:305–311.
  • Myers L. 2010. Postpartum plasma exchange in a woman with suspected thrombotic thrombocytopenic purpura (TTP) vs. hemolysis, elevated liver enzymes, and low platelet syndrome (HELLP): a case study. Nephrology Nursing Journal 37:399–402.
  • Neerhof MG, Zelman W, Sullivan T. 1989. Hepatic rupture in pregnancy. Obstetrical and Gynecological Survey 44:407–409.
  • Nunes JO, Turner MA, Fulcher AS. 2005. Abdominal imaging features of HELLP syndrome: a 10-year retrospective review. American Journal of Roentgenology 185:1205–1210.
  • O’Brien JM, Barton JR. 2005. Controversies with the diagnosis and management of HELLP syndrome. Clinical Obstetrics and Gynecology 448: 460–477.
  • Osmanagaoglu MA, Erdogan I, Zengin U, Bozkaya H. 2004. Comparison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome. Journal of Perinatal Medicine 32:481–485.
  • Paruk F, Moodley J. 2000. Maternal and neonatal outcome in early and late-onset pre-eclampsia. Seminars in Neonatology 5:197–207.
  • Pavlis T, Aloizos S, Aravosita P, Mystakelli C, Petrochilou D, Dimopoulos N, et al. 2009. Diagnosis and surgical management of spontaneous hepatic rupture associated with HELLP syndrome. Journal of Surgical Education 66:163–167.
  • Peral D, Armero R, Beltrán M, Onrubia X, Barberá M. 2006. Elevated magnesium levels treated successfully in a woman with pre-eclampsia and HELLP syndrome. Revista Espanola de Anestesiologia y Reanimacion 53:328–330.
  • Poo JL, Góngora J. 2006. Hepatic hematoma and hepatic rupture in pregnancy. Annals of Hepatology 5:224–226.
  • Prakash J, Niwas SS, Parekh A, Pandey LK, Sharatchandra L, Arora P et al 2010. Acute kidney injury in late pregnancy in developing countries. Renal Failure 32:309–313.
  • Reck T, Bussenius-Kammerer M, Ott R, Müller V, Beinder E, Hohenberger W. 2001. Surgical treatment of HELLP syndrome-associated liver rupture: an update. European Journal of Obstetrics, Gynecology, and Reproductive Biology 99:57–65.
  • Sibai BM. 1990. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? American Journal of Obstetrics and Gynecology 162:311–316.
  • Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. 1993. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). American Journal of Obstetrics and Gynecology 169:1000–1006.
  • Sibai BM. 2004a. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetrics and Gynecology 103:981–991.
  • Sibai BM. 2004b. Imitators of severe pre-eclampsia/eclampsia. Clinics in Perinatology 31:835–852.
  • Simic M, Tasic M, Stojiljkovic G, Draskovic D, Vukovic R. 2005. HELLP syndrome as a cause of unexpected rapid maternal death - a case report and review of the literature. International Journal of Legal Medicine 119:103–106.
  • Singhal N, Amin HJ, Pollard JK, Tough SC, Johnston DW, Clark DJ, et al. 2004. Maternal haemolysis, elevated liver enzymes and low platelets syndrome: perinatal and neurodevelopmental neonatal outcomes for infants weighing less than 1250. . Journal of Paediatrics and Child Health 40:121–126.
  • Steinborn A, Sohn C, Sayehli C, Niederhut A, Schmitt E, Kaufmann M. 2001. Preeclampsia, a pregnancy-specific disease, is associated with fetal monocyte activation. Clinical Immunology 100:305–313.
  • Steinborn A, Sohn C, Rebmann V, Grosse-Wilde H. 2000. Haemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome associated with increased maternal serum levels of soluble HLA-DR antigens. Australian and New Zealand Journal of Medicine 30:511–512.
  • Suarez B, Alves K, Senat MV, Fromageot J, Fischer C, Rosenberg P, et al. 2002. Abdominal pain and preeclampsia: sonographic findings in the maternal liver. Journal of Ultrasound in Medicine 21:1077–1083.
  • Thangaratinam S, Gallos ID, Meah N, Usman S, Ismail KM, Khan KS. 2011. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 90: 564–573.
  • Tsokos M, Longauer F, Kardosová V, Gavel A, Anders S, Schulz F. 2002. Maternal death in pregnancy from HELLP syndrome. A report of three medico-legal autopsy cases with special reference to distinctive histopathological alterations. International Journal of Legal Medicine 116: 50–53.
  • Tung CF, Peng YC, Chen GH, Chow WK, Yang DY, Hu WH. 2001. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome with acute cortical blindness. Zhonghua Yi Xue Za Zhi (Chinese Medical Journal, Taipei) 64:482–485.
  • Tyni T, Ekholm E, Pinko H. 1998. Pregnancy complications are frequent in long chain 3-hydroxy acyl co-enzyme A dehydrogenase deficiency. American Journal of Obstetrics and Gynecology 178:603–608.
  • Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F. 1989. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstetrics and Gynecology 73:97–102.
  • van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. 2005. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstetrical and Gynecological Survey 60:57–70.
  • Vidaeff AC, Yeomans ER. 2007. Corticosteroids for the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): what evidence? Minerva Ginecologica 59:183–190.
  • Weinstein L. 1982. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 142: 159–167.
  • Yücesoy G, Ozkan S, Bodur H, Tan T, Calişkan E, Vural B, et al. 2005. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Archives of Gynecology and Obstetrics 273:43–49.
  • Zeeman GG. 2009. Neurologic complications of pre-eclampsia. Seminars in Perinatology 33:166–172.
  • Zeirideen R, Kadir RA. 2009. Spontaneous postpartum hepatic rupture. Journal of Obstetrics and Gynaecology 29:155.
  • Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. 2002. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. American Journal of Pathology 160:1405–1423.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.